Moxalactam [moxalaktam]
- Terms
-
1-oxacefalosporin
6059-S
dvojsodná sůl moxalaktamu
latamoxef
latamoxef dvojsodný
Lilly 127935
Ly-127935
Ly127935
moxalactam
S-6059
-
1-Oxacephalosporin
6059-S
Disodium Latamoxef
Disodium Moxalactam
Festamoxin
Lamoxactam
Latamoxef
Lilly 127935
Ly-127935
Ly127935
Moxalactam Disodium
S-6059
Shiomarin
Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.
- DUI
- D009070 MeSH Browser
- CUI
- M0014142
- CAS
- 5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-
- Previous indexing
- Antibiotics (1966-1980); Cefamandole/analogs & derivatives (1978-1983); Cephalosporins (1966-1974); Cephamycins (1975-1977); Lactams (1972-1980)
- History note
- 84
- Public note
- 84
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine